Aurobindo Pharma, Indian Hotels Company, Sesa Sterlite and Adani Enterprises are among the other gainers.
GlaxoSmithKline Pharmaceuticals (GSK Pharma) surged 18.60% to Rs 2,927.40 after the company's overseas parent GlaxoSmithkline plc announced a voluntary open offer to acquire additional 2.06 crore equity shares of the company at Rs 3,100 per share. The announcement was before trading hours today, 16 December 2013. The stock topped the gainers in the BSE's 'A' group.
GlaxoSmithkline plc currently holds 50.67% stake in GSK Pharma. Its stake will rise to 75% if it gets the entire 2.06 crore equity shares through the voluntary open offer.
Pharmaceutical company Aurobindo Pharma spurted 12.62% to Rs 348.95, with the stock extending Friday's 3.99% gains triggered by the company receiving the final approval from the US Food & Drug Administration (USFDA) to manufacture and market Duloxetine Hydrochloride Delayed-Release Capsules 20mg (base), 30mg (base) and 60mg (base), which was earlier tentatively approved. The stock had risen 3.99% to settle at Rs 309.85 on Friday, 13 December 2013. The stock was second biggest gainer in 'A' group.
Hotel chain operator Indian Hotels Company jumped 7.31% to Rs 57.25. The stock was third biggest gainer in 'A' group.
Vedanta group firm Sesa Sterlite climbed 4.54% to Rs 200.50. The stock was fourth biggest gainer in 'A' group.
Commodities trading company Adani Enterprises rose 4.03% to Rs 258.25 on bargain hunting after the stock fell 10.88% in the preceding four trading sessions to Rs 248.25 on 13 December 2013, from a recent high of Rs 278.55 on 9 December 2013. The stock was fifth biggest gainer in 'A' group.
Powered by Capital Market - Live News